# Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma

> **NCT01793298** · PHASE1,PHASE2 · TERMINATED · sponsor: **Asmacure Ltée** · enrollment: 55 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** ASM-024

## Key facts

- **NCT ID:** NCT01793298
- **Lead sponsor:** Asmacure Ltée
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-12
- **Target enrollment:** 55 (ACTUAL)
- **Why stopped:** Lack of efficacy
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01793298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01793298, "Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01793298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*